Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment

Epirubicin (EPI) is an anti-cancerous chemotherapeutic drug that is an effective epimer of doxorubicin with less cardiotoxicity. Although EPI has fewer side effects than its analog, doxorubicin, this study aims to develop EPI nanoparticles as an improved formula of the conventional treatment of EPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Massadeh, Salam, Almohammed, Iman, Barhoush, Eman, Omer, Mustafa, Aldhawi, Nouf, Almalik, Abdulaziz, Alaamery, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070301/
https://www.ncbi.nlm.nih.gov/pubmed/33918625
http://dx.doi.org/10.3390/polym13081212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070301/
https://www.ncbi.nlm.nih.gov/pubmed/33918625
http://dx.doi.org/10.3390/polym13081212

Ejemplares similares